United States · FDA National Drug Code directory
METFORMIN HYDROCHLORIDE EXTENDED RELEASE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-454_1b06528a-d7ea-4ae9-b5c1-2cc175af1876
- Product NDC
- 71610-454
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- METFORMIN HYDROCHLORIDE
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160512
- Source listing expiry
- 20261231
Source-listed ingredients
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-30) · 71610-454-30
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-53) · 71610-454-53
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-60) · 71610-454-60
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-70) · 71610-454-70
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-80) · 71610-454-80
- 270 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-92) · 71610-454-92
- 360 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-454-94) · 71610-454-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →